Endorsed Event - Vaals 28 Feb to 02 Mar, 2018

2nd European Fatty Liver Conference (EFLC2018)


Nonalcoholic steatohepatitis (NASH) is an ongoing, worldwide clinical problem that is highly associated with co-morbidities, such as cardiovascular disease, diabetes and a variety of malignancies. During the EFLC2018, internationally-established experts in the field will create awareness of the most recent ideas, opportunities, challenges, and solutions for translational research in NASH (plenary sessions). Moreover, the EFLC2018 will highly contribute to the exchange of knowledge and/or expertise between clinicians, basic scientists, patients and/or patients organisations by means of interactive sessions (workshops, posters/pitches).

For more information, visit website.